Rexulti 0.5 mg
Rexulti 0.5 mg is a medicine authorised by Swissmedic under authorisation number 66475. The authorisation holder is Lundbeck (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 July 2018 and the authorisation is valid without a time limit. ATC code N05AX16 places the medicine in the group Psycholeptics.
| Authorisation number | 66475 |
|---|---|
| Name | Rexulti 0.5 mg |
| Full name | Rexulti 0.5 mg, Filmtabletten |
| Authorisation holder | Lundbeck (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N05AX16 |
| First authorisation | 17 July 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rexulti 0.5 mg, Filmtabletten | B | 17 July 2018 |
| 2 | Rexulti 1 mg, Filmtabletten | B | 17 July 2018 |
| 3 | Rexulti 2 mg, Filmtabletten | B | 17 July 2018 |
| 4 | Rexulti 3 mg, Filmtabletten | B | 17 July 2018 |
| 5 | Rexulti 4 mg, Filmtabletten | B | 17 July 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 7 | Tablette(n) | N05AX16 | 01.05.0. | B |
| 2 | 10 | Tablette(n) | N05AX16 | 01.05.0. | B |
| 3 | 28 | Tablette(n) | N05AX16 | 01.05.0. | B |
| 4 | 28 | Tablette(n) | N05AX16 | 01.05.0. | B |
| 5 | 28 | Tablette(n) | N05AX16 | 01.05.0. | B |
| 6 | 28 | Tablette(n) | N05AX16 | 01.05.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Rexulti 0.5 mg authorised in Switzerland?
Yes. Rexulti 0.5 mg is authorised by Swissmedic under authorisation number 66475, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rexulti 0.5 mg have?
Rexulti 0.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rexulti 0.5 mg?
The authorisation holder is Lundbeck (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.